微波辐射下水中6-氯嘌呤(核苷)及8-溴嘌呤核苷的脱卤反应

以6-氯嘌呤,6-氯嘌呤核苷或8-溴嘌呤核苷为原料,微波辐射下与水合肼反应生成相应的6-肼嘌呤(2a～2e),6-肼嘌呤核苷(2f和2g)或8-肼嘌呤核苷(2h和2i);2在微波辐射下经Wolff-Kishner-HuangMinlon还原反应得到6-脱氯嘌呤,6-脱氯嘌呤核苷或8-脱溴嘌呤核苷,总收率46%～83%,其结构经1HNMR和13CNMR表征。     

微波促进的非环核苷类化合物的合成

以嘌呤碱基和各种α,β-不饱和醛为原料,用三乙胺作为催化剂,在微波的促进下,通过Michael加成反应和原位还原,高效地合成了一系列非环核苷类新化合物.得到的目标化合物通过核磁共振图谱、高分辨质谱进行了确认.     

一类新的嘌呤核苷类似物的合成及简单生物活性检测

Convenient procedure for coupling of 1,2,3,5-tetra-O-acetyl-β-D-ribofuranose and 4-nitroimidazole was provided to obtain β-anomer as major product. A novel category of nucleoside analogues with an imidazole base moiety bearing amino-acid residue was designed and synthesized to develop selective and effective antiviral agents. They were evaluated for the anti-HBV activity.     

微波辐射下8-取代嘌呤核苷的绿色合成

8-溴嘌呤核苷与亲核试剂在水溶液中,于400W,95℃微波辐射5min合成了10种8-取代嘌呤核苷,收率72%～92%,其结构经1HNMR和13CNMR表征。     

5-去氮嘌呤核糖核苷类似物的设计与合成研究进展

综述了近年来有关5-去氮嘌呤核糖核苷类似物作为潜在生物活性(如抗病毒、抗肿瘤等)先导化合物的设计与合成研究进展.指出该类先导物的设计与合成主要基于以下两种途径:一是在去氮嘌呤碱基的4-位或5-位引入不同的取代基;二是在去氮嘌呤碱基的4-位或5-位引入不同取代基的同时,对核苷中的糖基进行修饰.并从这两种途径着手介绍了近年来该领域所取得的主要研究进展.     

新型类嘌呤脱氧核糖核苷类化合物的合成

以1,3,5-三-O-苯甲酰基-2-脱氧-2-β-氟-α-D-核糖为原料,通过溴代、与4-氯吡咯[2,3-d]嘧啶的钠盐偶合、4-氯的氨基化等反应,设计合成了一系列具有新型结构的4-取代-9-(2′-脱氧-2′-β-氟-β-D-呋喃糖基)吡咯[2,3-d]嘧啶类化合物,其化学结构经核磁共振、高分辨率质谱分析确证;并且初步探讨了反应条件和反应机理.结果表明,以无水四氢呋喃为溶剂,密闭高压回流反应,反应产率较高.     

无金属催化合成2,6-二氯嘌呤核苷和2-氯腺苷

提出了合成2,6-二氯嘌呤核苷和2-氯腺苷的新方法。 以商品化的2,6-二氯嘌呤和四乙酰核糖为原料,在5%(摩尔分数)三氟甲磺酸催化下,得到缩合物2',3',5'-三-O-乙酰基-2,6-二氯嘌呤核苷。 缩合物在浓H₂SO₄催化下,以89%的收率得到2,6-二氯嘌呤核苷;在NH₃/CH₃OH体系中氨解和脱除乙酰基,以92%的收率得到2-氯腺苷。 反应规模可以扩大到100 g,收率未降低。 该方法原料价格低廉,避免使用重金属催化剂,操作简便,中间体及产物可以通过结晶的方法纯化得到,显示出潜在的应用价值。     

可交联嘌呤类脱氧核苷类似物的合成

可交联嘌呤类脱氧核苷是天然脱氧核苷类似物,可与互补链中配对碱基上的胺基发生链间交联反应,导致DNA双链发生不可逆转的交联,对开发核苷类药物和控制修饰基因表达等方面有重要应用。本文开发了一条新的合成路径,该方法以商业化的1-氯-2-脱氧-3,5-二-O-对甲苯甲酰基-D-呋喃核糖为起始原料,经由简便的合成路线制备了目标产...     

双环笼状磷酸酯衍生物的研究Ⅵ:4-取代-2,6,7-三氧杂-1-磷杂双环[2.2.2]辛烷的反应研究

双环笼状亚磷酸酯类衍生物由于其笼状结构所引起的张力及高位阻性,使得它同一般直链亚磷酸酯类化合物相比,在亲核取代反应性等方面有着明显的不同.本文用化合物1分别同SO_2Cl_2,Cl_2,Br_2,PCl_5等反应,结果表明,1均发生了类Arbuzov反应,生成具有相同立体构型的开环产物.本文还对化合物2的磷酰化反应进行了研究,发现在这类高位阻性的双环笼状亚磷酸酯衍生物的磷酰化反应中,DMAP是一个较有效的催化剂.     

嘌呤N-6-吡啶盐中间体的形成及其在嘌呤核苷合成上的应用

本文报道以次黄苷为原料, 经酯化, 再在缩合剂4-氯苯磷酰二氯存在下与吡啶反应, 形成嘌呤N-6-吡啶盐中间体2, 该中间体2分别与碱性强弱不同的胺或氨及2moldm^-^3NaOH的醇溶液在室温反应, 可方便的合成6-NH2, 6-OCH3以及6-OCH2CH3-9-(β-D-呋喃核糖)嘌呤衍生物。并对以上产物形成的机制作了探讨。     

Microwave chemistry: Synthesis of purine and pyrimidine nucleosides using microwave radiation

Pyrimidine and purine nucleosides have a remarkable and comprehensive impact on medicinal chemistry and pharmaceutical industries. They become key parts of the growing interdisciplinary area of antimetabolites. The paramount importance of the nucleoside analogs triggered their broader use in treatment of critical diseases such as cancer, malignancies, microbial infection, and autoimmune diseases. Recent advances in their synthetic strategies through microwave-assisted organic synthesis (MAOS) have been reviewed.     

Synthesis of novel C6-phosphonated purine nucleosides under microwave irradiation by SNAr-Arbuzov reaction

Novel C6-phosphonated purine nucleosides were obtained in good to excellent isolated yields by the simple and catalyst-free SNAr-Arbuzov reaction of trialkyl phosphite with 6-choloropurine nucleosides, including a series of nonsugar carbon nucleosides. Shorter reaction times were needed, and substantially higher yields were obtained under microwave irradiation conditions compared with conventional heating conditions.     

Microwave-enhanced Sonogashira coupling reaction of substituted pyrimidinones and pyrimidine nucleosides

Direct microwave-enhanced Sonogashira coupling of several pyrimidinones and uridine with alkynes, PdCl₂(PPh₃)₂, Et₃N and CuI to give the corresponding 5-alkynyl derivatives is described.     

Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry

Urinary‐modified nucleosides have a potential role as cancer biomarkers for a number of malignant diseases. High performance liquid chromatography (HPLC) was combined with full‐scan mass spectrometry, MS/MS analysis and accurate mass measurements in order to identify purine nucleosides purified from urine. Potential purine nucleosides were assessed by their evident UV absorbance in the HPLC chromatogram and then further examined by the mass spectrometric techniques. In this manner, numerous modified purine nucleosides were identified in the urine samples from cancer patients including xanthine, adenosine, N1‐methyladenosine, 5′‐deoxy‐5′‐methylthioadenosine, 2‐methyladenosine, N6‐threonylcarbamoyladenosine, inosine, N1‐methylinosine, guanosine, N1‐methylguanosine, N7‐methylguanine, N2‐methylguanosine, N2,N2‐dimethyguanosine, N2,N2,N7‐trimethylguanosine. Furthermore, a number of novel purine nucleosides were tentatively identified via critical interpretation of the combined mass spectrometric data including N3‐methyladenosine, N7‐methyladenine, 5′‐dehydro‐2′‐deoxyinosine, N3‐methylguanine, O6‐methylguanosine, N1,N2,N7‐trimethylguanosine, N1‐methyl‐N2‐ethylguanosine and N7‐methyl‐N1‐ethylguanosine. Copyright © 2009 John Wiley & Sons, Ltd.     

Unambiguous structural elucidation of base-modified purine nucleosides using NMR

A general and unambiguous approach has been developed for structural elucidation of modified purine nucleosides using NMR spectroscopy. Systematic assignment of proton and carbon signals of modified nucleosides was firmly established by COSY and the anomerism of the glycosidic linkage of synthetic nucleosides clearly elucidated by NOESY experiments. Characteristic properties of 15N-isotopic labelling at specific positions of nucleosides were also employed for structural studies. The reported approach is applicable to other modified nucleosides and nucleotides, as well as nucleobases.     

Synthesis of 2′,3′-dideoxy-6′-fluorocarbocyclic nucleosides via Reformatskii-Claisen rearrangement

2′,3′-Dideoxy-6′-fluorocarbocyclic nucleosides, analogues of highly bioactive carbovir and abacavir were synthesized. The notable steps were the incorporation of fluoromethylene group by way of silicon-induced Reformatskii-Claisen rearrangement of allyl bromofluoroacetate, the construction of the carbocyclic ring via ring-closing metathesis (RCM) and the introduction of base by Mitsunobu reaction.     

Synthesis, structure, and biological evaluation of C-2 sulfonamido pyrimidine nucleosides

The C-2 sulfonamido pyrimidine nucleosides were prepared by opening the 2,2′- or 2,3′-bond in anhydronucleosides under nucleophilic attack of sulfonamide anions. Reaction of the sodium salt of p-toluenesulfonamide or 2-(aminosulfonyl)-N,N-dimethylnicotinamide with 2,2′-anhydro-1-(β-d-arabinofuranosyl)cytosine gave the C-2 sulfonamido derivatives in excellent yields. Ring opening of the less reactive 2,2′-anhydrouridine and 2,3′-anhydrothymidine could be accomplished with DBU/CH₃CN activation of p-toluenesulfonamide, giving moderate yields for C-2 sulfonamido derivatives. The action of acetic acid or ZnBr₂/CH₂Cl₂ on 5-methyl-N²-tosyl-1-(2-deoxy-5-O-trityl-β-d-threo-pentofuranosyl)isocytosine led to the cleavage of both the protection group and the nucleoside bond, yielding 5-methyl-N²-tosylisocytosine as the major product. Structures of the prepared C-2 sulfonamido nucleosides were confirmed by the 1D and 2D NMR experiments, and X-ray structural analysis of 4-imino-N²-tosylamino-1-(β-d-arabinofuranosyl)pyrimidine. Both methods confirmed β-configuration and anti-conformation of the 2-sulfonamido nucleosides. The investigated compounds displayed moderate inhibition of tumor cell growth in vitro, as determined by the MTT assay using six different human tumor cell lines.     

A concise method for synthesis of diaryl aryl- or alkylphosphonates

A convenient method has been developed to synthesize diaryl arylphosphonates from triaryl phosphites, triethyl phosphite, and aromatic halides. The new method relies on the triethyl phosphite assisted nickel catalyzed Arbuzov reaction and can be applied to synthesize certain diaryl alkylphosphonates without catalysts.     

碘催化合成三乙基膦酰乙酸酯

首次报道了碘对M ichaelArbuzov重排反应的催化作用.以亚磷酸三乙酯与2-卤代乙酸乙酯为原料,碘作催化剂,反应温度80℃,反应时间2 h,三乙基膦酰乙酸酯的产率达到90%-98%.